메뉴 건너뛰기




Volumn 107, Issue 9, 2015, Pages

Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome

(24)  Ouakrim, Driss Ait a   Dashti, Seyedeh Ghazaleh a   Chau, Rowena a   Buchanan, Daniel D a,b   Clendenning, Mark b   Rosty, Christophe b,c   Winship, Ingrid M b,d   Young, Joanne P e,f,g   Giles, Graham G a,h   Leggett, Barbara i   Macrae, Finlay A b,d   Ahnen, Dennis J j   Casey, Graham k   Gallinger, Steven l   Haile, Robert W m   Le Marchand, Loïc n   Thibodeau, Stephen N o   Lindor, Noralane M p   Newcomb, Polly A q,r   Potter, John D q,r,s   more..


Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

EID: 84942022355     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv170     Document Type: Article
Times cited : (85)

References (60)
  • 1
    • 67650924286 scopus 로고    scopus 로고
    • Review of the Lynch syndrome: History, molecular genetics, screening, differential diagnosis, and medicolegal rami-fcations
    • Lynch HT, Lynch PM, Lanspa SJ, et al. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal rami-fcations. Clin Genet. 2009;76(1):1-18.
    • (2009) Clin Genet. , vol.76 , Issue.1 , pp. 1-18
    • Lynch, H.T.1    Lynch, P.M.2    Lanspa, S.J.3
  • 2
    • 0034538160 scopus 로고    scopus 로고
    • Population carrier frequency of hMSH2 and hMLH1 mutations
    • Dunlop MG, Farrington SM, Nicholl I, et al. Population carrier frequency of hMSH2 and hMLH1 mutations. Br J Cancer. 2000;83(12):1643-1645.
    • (2000) Br J Cancer. , vol.83 , Issue.12 , pp. 1643-1645
    • Dunlop, M.G.1    Farrington, S.M.2    Nicholl, I.3
  • 3
    • 78650844345 scopus 로고    scopus 로고
    • The search for unaffected individuals with Lynch syndrome: Do the ends justify the means?
    • Hampel H, de la Chapelle A. The search for unaffected individuals with Lynch syndrome: do the ends justify the means? Cancer Prev Res (Phila). 2011;4(1):1-5.
    • (2011) Cancer Prev Res (Phila). , vol.4 , Issue.1 , pp. 1-5
    • Hampel, H.1    De La Chapelle, A.2
  • 4
    • 0027966880 scopus 로고
    • A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden
    • Aaltonen LA, Sankila R, Mecklin JP, et al. A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev. 1994;18(1):57-63.
    • (1994) Cancer Detect Prev. , vol.18 , Issue.1 , pp. 57-63
    • Aaltonen, L.A.1    Sankila, R.2    Mecklin, J.P.3
  • 5
    • 13744255043 scopus 로고    scopus 로고
    • Application of genetics to the prevention of colorectal cancer. Recent results in cancer research 2005;Fortschritte der Krebsforschung
    • Hopper JL. Application of genetics to the prevention of colorectal cancer. Recent results in cancer research 2005;Fortschritte der Krebsforschung. Pro-gres dans les recherches sur le cancer. 166:17-33.
    • Pro-gres dans les Recherches sur le Cancer. , vol.166 , pp. 17-33
    • Hopper, J.L.1
  • 6
    • 84873942317 scopus 로고    scopus 로고
    • Cancer risks for MLH1 and MSH2 mutation carriers
    • Dowty JG, Win AK, Buchanan DD, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat. 2013;34(3):490-497.
    • (2013) Hum Mutat. , vol.34 , Issue.3 , pp. 490-497
    • Dowty, J.G.1    Win, A.K.2    Buchanan, D.D.3
  • 7
    • 0034011564 scopus 로고    scopus 로고
    • Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer
    • Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118(5):829-834.
    • (2000) Gastroenterology. , vol.118 , Issue.5 , pp. 829-834
    • Jarvinen, H.J.1    Aarnio, M.2    Mustonen, H.3
  • 8
    • 77951758579 scopus 로고    scopus 로고
    • Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
    • Cairns SR, Scholefeld JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666-689.
    • (2010) Gut. , vol.59 , Issue.5 , pp. 666-689
    • Cairns, S.R.1    Scholefeld, J.H.2    Steele, R.J.3
  • 9
    • 42949177399 scopus 로고    scopus 로고
    • Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
    • Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58(3):130-160.
    • (2008) CA Cancer J Clin. , vol.58 , Issue.3 , pp. 130-160
    • Levin, B.1    Lieberman, D.A.2    McFarland, B.3
  • 11
    • 84876900933 scopus 로고    scopus 로고
    • Revised guidelines for the clinical management of Lynch syndrome (HNPCC): Recommendations by a group of European experts
    • Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013;62(6):812-823.
    • (2013) Gut. , vol.62 , Issue.6 , pp. 812-823
    • Vasen, H.F.1    Blanco, I.2    Aktan-Collan, K.3
  • 12
    • 33749067855 scopus 로고    scopus 로고
    • Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review
    • Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review. JAMA. 2006;296(12):1507-1517.
    • (2006) JAMA , vol.296 , Issue.12 , pp. 1507-1517
    • Lindor, N.M.1    Petersen, G.M.2    Hadley, D.W.3
  • 13
    • 37349041679 scopus 로고    scopus 로고
    • Aspirin dose and duration of use and risk of colorectal cancer in men
    • Chan AT, Giovannucci EL, Meyerhardt JA, et al. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology. 2008;134(1):21-28.
    • (2008) Gastroenterology. , vol.134 , Issue.1 , pp. 21-28
    • Chan, A.T.1    Giovannucci, E.L.2    Meyerhardt, J.A.3
  • 14
    • 65349152488 scopus 로고    scopus 로고
    • Aspirin and non-steroidal anti-infammatory drugs for cancer prevention: An international consensus statement
    • Cuzick J, Otto F, Baron JA, et al. Aspirin and non-steroidal anti-infammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol. 2009;10(5):501-507.
    • (2009) Lancet Oncol. , vol.10 , Issue.5 , pp. 501-507
    • Cuzick, J.1    Otto, F.2    Baron, J.A.3
  • 15
    • 34248157118 scopus 로고    scopus 로고
    • Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies
    • Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007;369(9573):1603-1613.
    • (2007) Lancet. , vol.369 , Issue.9573 , pp. 1603-1613
    • Flossmann, E.1    Rothwell, P.M.2
  • 16
    • 78650215449 scopus 로고    scopus 로고
    • Long-term effect of aspirin on colo-rectal cancer incidence and mortality: 20-year follow-up of fve randomised trials
    • Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colo-rectal cancer incidence and mortality: 20-year follow-up of fve randomised trials. Lancet. 2010;376(9754):1741-1750.
    • (2010) Lancet. , vol.376 , Issue.9754 , pp. 1741-1750
    • Rothwell, P.M.1    Wilson, M.2    Elwin, C.E.3
  • 17
    • 60749128400 scopus 로고    scopus 로고
    • Aspirin for the chemoprevention of colo-rectal adenomas: Meta-analysis of the randomized trials
    • Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colo-rectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst. 2009;101(4):256-266.
    • (2009) J Natl Cancer Inst. , vol.101 , Issue.4 , pp. 256-266
    • Cole, B.F.1    Logan, R.F.2    Halabi, S.3
  • 18
    • 84893158245 scopus 로고    scopus 로고
    • The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: A randomised trial
    • Ishikawa H, Mutoh M, Suzuki S, et al. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. Gut. 2014;63(11):1755-1759.
    • (2014) Gut. , vol.63 , Issue.11 , pp. 1755-1759
    • Ishikawa, H.1    Mutoh, M.2    Suzuki, S.3
  • 19
    • 57749107623 scopus 로고    scopus 로고
    • Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome
    • Burn J, Bishop DT, Mecklin JP, et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med. 2008;359(24):2567-2578.
    • (2008) N Engl J Med. , vol.359 , Issue.24 , pp. 2567-2578
    • Burn, J.1    Bishop, D.T.2    Mecklin, J.P.3
  • 20
    • 83955161674 scopus 로고    scopus 로고
    • Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial
    • Burn J, Gerdes AM, Macrae F, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet. 2011;378(9809):2081-2087.
    • (2011) Lancet. , vol.378 , Issue.9809 , pp. 2081-2087
    • Burn, J.1    Gerdes, A.M.2    Macrae, F.3
  • 21
    • 38849170356 scopus 로고    scopus 로고
    • Colon Cancer Family Registry: An international resource for studies of the genetic epidemiology of colon cancer
    • Newcomb PA, Baron J, Cotterchio M, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2331-2343.
    • (2007) Cancer Epidemiol Biomarkers Prev. , vol.16 , Issue.11 , pp. 2331-2343
    • Newcomb, P.A.1    Baron, J.2    Cotterchio, M.3
  • 22
    • 78651074177 scopus 로고    scopus 로고
    • Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases
    • Rumilla K, Schowalter K V, Lindor NM, et al. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn. 2011;13(1):93-99.
    • (2011) J Mol Diagn. , vol.13 , Issue.1 , pp. 93-99
    • Rumilla, K.1    Schowalter, K.V.2    Lindor, N.M.3
  • 23
    • 26644441586 scopus 로고    scopus 로고
    • Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer
    • Southey MC, Jenkins MA, Mead L, et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol. 2005;23(27):6524-6532.
    • (2005) J Clin Oncol. , vol.23 , Issue.27 , pp. 6524-6532
    • Southey, M.C.1    Jenkins, M.A.2    Mead, L.3
  • 24
    • 48549099663 scopus 로고    scopus 로고
    • The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
    • Senter L, Clendenning M, Sotamaa K, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology. 2008;135(2):419-428.
    • (2008) Gastroenterology. , vol.135 , Issue.2 , pp. 419-428
    • Senter, L.1    Clendenning, M.2    Sotamaa, K.3
  • 25
    • 84860605783 scopus 로고    scopus 로고
    • Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study
    • Win AK, Young JP, Lindor NM, et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012;30(9):958-964.
    • (2012) J Clin Oncol. , vol.30 , Issue.9 , pp. 958-964
    • Win, A.K.1    Young, J.P.2    Lindor, N.M.3
  • 26
    • 21344437509 scopus 로고    scopus 로고
    • A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes
    • Antoniou AC, Goldgar DE, Andrieu N, et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol. 2005;29(1):1-11.
    • (2005) Genet Epidemiol. , vol.29 , Issue.1 , pp. 1-11
    • Antoniou, A.C.1    Goldgar, D.E.2    Andrieu, N.3
  • 27
    • 33746853116 scopus 로고    scopus 로고
    • Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: A report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group
    • Andrieu N, Easton D F, Chang-Claude J, et al. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol. 2006;24(21):3361-3366.
    • (2006) J Clin Oncol. , vol.24 , Issue.21 , pp. 3361-3366
    • Andrieu, N.1    Easton, D.F.2    Chang-Claude, J.3
  • 28
    • 41649097333 scopus 로고    scopus 로고
    • Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
    • Antoniou AC, Spurdle AB, Sinilnikova OM, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 2008;82(4):937-948.
    • (2008) Am J Hum Genet. , vol.82 , Issue.4 , pp. 937-948
    • Antoniou, A.C.1    Spurdle, A.B.2    Sinilnikova, O.M.3
  • 29
    • 79953226290 scopus 로고    scopus 로고
    • Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers
    • Win AK, Dowty JG, Antill YC, et al. Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol. 2011;117(4):899-905.
    • (2011) Obstet Gynecol. , vol.117 , Issue.4 , pp. 899-905
    • Win, A.K.1    Dowty, J.G.2    Antill, Y.C.3
  • 30
    • 76749132847 scopus 로고    scopus 로고
    • Smoking and colorectal cancer in lynch syndrome: Results from the colon cancer family registry and the university of Texas M.D. Anderson cancer center
    • Pande M, Lynch PM, Hopper JL, et al. Smoking and Colorectal Cancer in Lynch Syndrome: Results from the Colon Cancer Family Registry and The University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010;16(4):1331-1339.
    • (2010) Clin Cancer Res. , vol.16 , Issue.4 , pp. 1331-1339
    • Pande, M.1    Lynch, P.M.2    Hopper, J.L.3
  • 31
    • 0003964363 scopus 로고    scopus 로고
    • American Cancer Society Atlanta: American Cancer Society
    • American Cancer Society. Cancer Facts & Figures 2013. In. Atlanta: American Cancer Society; 2013.
    • (2013) Cancer Facts & Figures 2013
  • 32
    • 33645826906 scopus 로고    scopus 로고
    • Cancer risks for mismatch repair gene mutation carriers: A population-based early onset case-family study
    • Jenkins MA, Baglietto L, Dowty JG, et al. Cancer Risks For Mismatch Repair Gene Mutation Carriers: A Population-Based Early Onset Case-Family Study. Clin Gastroenterol Hepatol. 2006;4(4):489-498.
    • (2006) Clin Gastroenterol Hepatol. , vol.4 , Issue.4 , pp. 489-498
    • Jenkins, M.A.1    Baglietto, L.2    Dowty, J.G.3
  • 33
    • 70449647008 scopus 로고
    • Proportional hazards tests and diagnostics based on weighted residuals
    • Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515-526.
    • (1994) Biometrika. , vol.81 , Issue.3 , pp. 515-526
    • Grambsch, P.M.1    Therneau, T.M.2
  • 35
    • 0002745670 scopus 로고    scopus 로고
    • Regression standard errors in clustered samples
    • Rogers W. Regression standard errors in clustered samples. Stata Technical Bulletin. 1999;3:19-23.
    • (1999) Stata Technical Bulletin. , vol.3 , pp. 19-23
    • Rogers, W.1
  • 36
    • 0033918632 scopus 로고    scopus 로고
    • A note on robust variance estimation for cluster-correlated data
    • Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56(2):645-646.
    • (2000) Biometrics. , vol.56 , Issue.2 , pp. 645-646
    • Williams, R.L.1
  • 37
    • 80052225995 scopus 로고    scopus 로고
    • Modifcation of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes
    • Rebbeck TR, Mitra N, Domchek SM, et al. Modifcation of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Res. 2011;71(17):5792-5805.
    • (2011) Cancer Res. , vol.71 , Issue.17 , pp. 5792-5805
    • Rebbeck, T.R.1    Mitra, N.2    Domchek, S.M.3
  • 38
    • 84874372330 scopus 로고    scopus 로고
    • Dose-risk and duration-risk relationships between aspirin and colorectal cancer: A meta-analysis of published cohort studies
    • Ye X, Fu J, Yang Y, et al. Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS One. 2013;8(2):e57578.
    • (2013) PLoS One. , vol.8 , Issue.2 , pp. e57578
    • Ye, X.1    Fu, J.2    Yang, Y.3
  • 39
    • 0037464808 scopus 로고    scopus 로고
    • Interaction revisited: The difference between two estimates
    • Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326(7382):219.
    • (2003) BMJ , vol.326 , Issue.7382 , pp. 219
    • Altman, D.G.1    Bland, J.M.2
  • 40
    • 79955832527 scopus 로고    scopus 로고
    • A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis
    • Burn J, Bishop DT, Chapman PD, et al. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila). 2011;4(5):655-665.
    • (2011) Cancer Prev Res (Phila). , vol.4 , Issue.5 , pp. 655-665
    • Burn, J.1    Bishop, D.T.2    Chapman, P.D.3
  • 41
    • 0027197062 scopus 로고
    • Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
    • Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993;328(18):1313-1316.
    • (1993) N Engl J Med. , vol.328 , Issue.18 , pp. 1313-1316
    • Giardiello, F.M.1    Hamilton, S.R.2    Krush, A.J.3
  • 42
    • 0242486770 scopus 로고    scopus 로고
    • Rofecoxib reduces polyp recurrence in familial polyposis
    • Hallak A, Alon-Baron L, Shamir R, et al. Rofecoxib reduces polyp recurrence in familial polyposis. Dig Dis Sci. 2003;48(10):1998-2002.
    • (2003) Dig Dis Sci. , vol.48 , Issue.10 , pp. 1998-2002
    • Hallak, A.1    Alon-Baron, L.2    Shamir, R.3
  • 43
    • 17744418769 scopus 로고    scopus 로고
    • The effect of celecoxib, a cycloox-ygenase-2 inhibitor, in familial adenomatous polyposis
    • Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cycloox-ygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000;342(26):1946-1952.
    • (2000) N Engl J Med. , vol.342 , Issue.26 , pp. 1946-1952
    • Steinbach, G.1    Lynch, P.M.2    Phillips, R.K.3
  • 44
    • 0028850446 scopus 로고
    • Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-infammatory drug regimen in reversing adenomas exceeding 33 months
    • Winde G, Schmid KW, Schlegel W, et al. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-infammatory drug regimen in reversing adenomas exceeding 33 months. Dis Colon Rectum. 1995;38(8):813-830.
    • (1995) Dis Colon Rectum. , vol.38 , Issue.8 , pp. 813-830
    • Winde, G.1    Schmid, K.W.2    Schlegel, W.3
  • 45
    • 0029829551 scopus 로고    scopus 로고
    • Nonsteroidal anti-infam-matory drug use and protection against colorectal cancer in women
    • Reeves MJ, Newcomb PA, Trentham-Dietz A, et al. Nonsteroidal anti-infam-matory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 1996;5(12):955-960.
    • (1996) Cancer Epidemiol Biomarkers Prev. , vol.5 , Issue.12 , pp. 955-960
    • Reeves, M.J.1    Newcomb, P.A.2    Trentham-Dietz, A.3
  • 46
    • 0023687241 scopus 로고
    • Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study
    • Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 1988;48(15):4399-4404.
    • (1988) Cancer Res. , vol.48 , Issue.15 , pp. 4399-4404
    • Kune, G.A.1    Kune, S.2    Watson, L.F.3
  • 47
    • 0037138743 scopus 로고    scopus 로고
    • Nonsteroidal anti-infammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
    • Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-infammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94(4):252-266.
    • (2002) J Natl Cancer Inst. , vol.94 , Issue.4 , pp. 252-266
    • Thun, M.J.1    Henley, S.J.2    Patrono, C.3
  • 48
    • 34249673868 scopus 로고    scopus 로고
    • Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
    • Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 2007;356(21):2131-2142.
    • (2007) N Engl J Med. , vol.356 , Issue.21 , pp. 2131-2142
    • Chan, A.T.1    Ogino, S.2    Fuchs, C.S.3
  • 49
    • 0033615352 scopus 로고    scopus 로고
    • PPARdelta is an APC-regulated target of nonsteroidal anti-infammatory drugs
    • He TC, Chan TA, Vogelstein B, et al. PPARdelta is an APC-regulated target of nonsteroidal anti-infammatory drugs. Cell. 1999;99(3):335-345.
    • (1999) Cell. , vol.99 , Issue.3 , pp. 335-345
    • He, T.C.1    Chan, T.A.2    Vogelstein, B.3
  • 50
    • 0028803728 scopus 로고
    • Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
    • Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995;83(3):493-501.
    • (1995) Cell. , vol.83 , Issue.3 , pp. 493-501
    • Tsujii, M.1    DuBois, R.N.2
  • 51
    • 0031882916 scopus 로고    scopus 로고
    • Mechanisms underlying nonsteroi-dal antiinfammatory drug-mediated apoptosis
    • Chan TA, Morin PJ, Vogelstein B, et al. Mechanisms underlying nonsteroi-dal antiinfammatory drug-mediated apoptosis. Proc Natl Acad Sci USA. 1998;95(2):681-686.
    • (1998) Proc Natl Acad Sci USA. , vol.95 , Issue.2 , pp. 681-686
    • Chan, T.A.1    Morin, P.J.2    Vogelstein, B.3
  • 52
    • 0035951493 scopus 로고    scopus 로고
    • Cancer research. Anti-infammatories inhibit cancer growth-but how?
    • Marx J. Cancer research. Anti-infammatories inhibit cancer growth-but how? Science. 2001;291(5504):581-582.
    • (2001) Science. , vol.291 , Issue.5504 , pp. 581-582
    • Marx, J.1
  • 53
    • 78650840096 scopus 로고    scopus 로고
    • Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}
    • Greenspan EJ, Madigan JP, Boardman LA, et al. Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}. Cancer Prev Res (Phila). 2011;4(1):161-171.
    • (2011) Cancer Prev Res (Phila). , vol.4 , Issue.1 , pp. 161-171
    • Greenspan, E.J.1    Madigan, J.P.2    Boardman, L.A.3
  • 54
    • 84860291337 scopus 로고    scopus 로고
    • Does aspirin really reduce the risk of colon cancer?
    • author reply 1587
    • Jankowski J, Barr H, Moayyedi P. Does aspirin really reduce the risk of colon cancer? Lancet. 2012;379(9826):1586-1587; author reply 1587.
    • (2012) Lancet. , vol.379 , Issue.9826 , pp. 1586-1587
    • Jankowski, J.1    Barr, H.2    Moayyedi, P.3
  • 55
    • 77956830345 scopus 로고    scopus 로고
    • Diagnosis and management of Barrett's oesophagus
    • Jankowski J, Barr H, Wang K, et al. Diagnosis and management of Barrett's oesophagus. BMJ. 2010;341:c4551.
    • (2010) BMJ , vol.341 , pp. c4551
    • Jankowski, J.1    Barr, H.2    Wang, K.3
  • 56
    • 0023933549 scopus 로고
    • Clinicopathological features of non-steroidal antiinfammatory drug-induced small intestinal strictures
    • Bjarnason I, Price AB, Zanelli G, et al. Clinicopathological features of non-steroidal antiinfammatory drug-induced small intestinal strictures. Gastro-enterology. 1988;94(4):1070-1074.
    • (1988) Gastro-enterology. , vol.94 , Issue.4 , pp. 1070-1074
    • Bjarnason, I.1    Price, A.B.2    Zanelli, G.3
  • 57
    • 84907754172 scopus 로고    scopus 로고
    • Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease
    • Ishihara M, Ohmiya N, Nakamura M, et al. Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease. Aliment Pharmacol Ther. 2014;40(5):538-547.
    • (2014) Aliment Pharmacol Ther. , vol.40 , Issue.5 , pp. 538-547
    • Ishihara, M.1    Ohmiya, N.2    Nakamura, M.3
  • 58
    • 0032724388 scopus 로고    scopus 로고
    • The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption
    • Kaufman DW, Kelly JP, Wiholm BE, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol. 1999;94(11):3189-3196.
    • (1999) Am J Gastroenterol. , vol.94 , Issue.11 , pp. 3189-3196
    • Kaufman, D.W.1    Kelly, J.P.2    Wiholm, B.E.3
  • 59
    • 84922532328 scopus 로고    scopus 로고
    • Estimates of benefts and harms of prophylactic use of aspirin in the general population
    • Cuzick J, Thorat MA, Bosetti C, et al. Estimates of benefts and harms of prophylactic use of aspirin in the general population. Ann Oncol. 2014;26(1):47-57.
    • (2014) Ann Oncol. , vol.26 , Issue.1 , pp. 47-57
    • Cuzick, J.1    Thorat, M.A.2    Bosetti, C.3
  • 60
    • 84922908649 scopus 로고    scopus 로고
    • Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women
    • van Kruijsdijk RC, Visseren FL, Ridker PM, et al. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women. Heart. 2014;101(5):369-376.
    • (2014) Heart. , vol.101 , Issue.5 , pp. 369-376
    • Van Kruijsdijk, R.C.1    Visseren, F.L.2    Ridker, P.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.